APOH and systemic lupus erythematosus: In SLE, plasmatic levels of F2-isoprostane correlate with high disease activity, renal manifestations, mitochondrial function, and APS anti-β2-glycoprotein I (anti-β2GPI) presenting with multiple clinical phenotypes and complications [25,26].